Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00417573
Recruitment Status : Completed
First Posted : January 1, 2007
Last Update Posted : January 1, 2007
Grifols Therapeutics LLC
Information provided by:
The Center for Rheumatic Disease, Allergy, & Immunology

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : December 2006